Intravaginal misoprostol can reduces blood loss in myomectomy

Phase 2

• Conditions: uterus myoma.; D25.1 Intramural leiomyoma of uterus D25.2 Subserosal leiomyoma of uterus; D25.1 , D2

• Registration Number: IRCT2013100714927N1
• Lead Sponsor: Vice chancellor for research , Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 64

Inclusion Criteria

Inclusion criteria : Women with intramural or subsrosal uterus myoma that they are the case of laparatomy myomectomy .
Exclusion criteria : Vaginal myomectomy ; Myomectomy assisted by hysteroscopy ; Virginity ; Misoprostol contraindications : liver diseas ; Epilepsy ; Sesnsitivity to misoprostol .

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hemoglobin count . Timepoint: Hemoglobin before & 6 houre & 12 houerafter operation. Method of measurement: Blood examination.

Secondary Outcome Measures

Name	Time	Method
Operation time. Timepoint: Intraoperative. Method of measurement: Time.